CompletedNCT00205699
Metabolic effects of antipsychotic medicines in children with mental health conditions
About this title
Read the official source — NCT00205699Medication studyAges 6–18United StatesBipolarity
Understand this study
Who was this study for?
Listed age limits: 6 years to 18 years.
- Listed locations
- St LouisSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateStarted: April 2006
- Recruitment status
- Completed
- Enrollment listed in the registry
- 144
- Sponsor
- Washington University School of Medicine
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 6 Years to 18 Years
- Official registry ID
- NCT00205699
- Official title
Show the full official title
Metabolic Effects of Antipsychotics in Children
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
St Louis
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Washington University School of Medicine, a university.
Did this study involve medication?
Yes. The study involved medication, including risperidone, olanzapine and aripiprazole.
Who was this study for?
Listed age limits: 6 years to 18 years.
